{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016227","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.098421+00:00","generated_at":"2026-05-18T22:39:30.251164+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"PAVmed subsidiary Veris Health raises $2.5M in equity and warrant offering","bullets":["Veris sold 1,785,714 common shares and warrants at $1.40 per share unit.","Gross proceeds of ~$2.5M for development of implantable physiological monitor and working capital.","After offering, PAVmed owns 75.3% of Veris on a fully-diluted basis.","Warrants exercisable after 6 months at $1.40, expire 5 years from exercise or 60 days post-FDA approval.","Investors granted anti-dilution protection and 100% participation rights in future equity raises."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016227","json":"https://secwatch.observer/filing/0001641172-25-016227.json","markdown":"https://secwatch.observer/filing/0001641172-25-016227.md","text":"https://secwatch.observer/filing/0001641172-25-016227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000164117225016227/0001641172-25-016227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000164117225016227/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:39:30.251164+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}